What is the current stock price of BioAdaptives, Inc. (BDPT)?

As of the latest market data, BioAdaptives, Inc. (BDPT) is trading at $0.01. The stock has seen a gain of 10.00% today.

Does BioAdaptives, Inc. (BDPT) pay a dividend?

Based on current data, BioAdaptives, Inc. does not have a confirmed active dividend policy.

What is the market cap of BioAdaptives, Inc.?

The current market capitalization of BioAdaptives, Inc. (BDPT) is approximately unavailable.

BDPT

BioAdaptives, Inc.·Consumer Defensive

0.01

10.000%(+0.00)

Market Closed

0.01

26.364%(+0.00)

After Hours

Last Updated: — ET

52W L: $0.0152W H: $0.12

Company Profile

BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

Sector

Consumer Defensive

Industry

Packaged Foods

Employees

IPO Date

2014-07-09

Beta

1.34

Websitewww.shopbioadaptives.com↗